J EXP CLIN CANC RES 润色咨询

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

出版年份:1982 年文章数:2075 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:6.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=56a17532, cover=https://img.medsci.cn/images/journal/cover/2021/idn_202109271315366260.jpg, fullname=JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, abbr=J EXP CLIN CANC RES, pyear=1982, frequence=Irregular, articleNumbers=2075, citedSelf2015=6.5, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均1.46月, reviewFee=290.0, pageFee=1985.0, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1756-9966, greenSci=https://www.greensci.net/search?kw=1756-9966, scijournal=https://www.scijournal.org/impact-factor-of-J-EXP-CLIN-CANC-RES.shtml, medsciHotlightString=null, medsciHotlightRealtime=26.053, medsciHotlight=43.871, medsciHotlight5year=50.0113, citescore=0.0, hIndex=81, impactFactor=11.3, orgnization=BioMed Central Ltd., orgnizationUrl=null, country=United Kingdom, countryCn=英国, isOa=1, isOaString=是, sciScie=null, bigclassCas=医学 2区, smallclassCas=, website=https://jeccr.biomedcentral.com/, websiteHits=36922, guideForAuthor=https://jeccr.biomedcentral.com/submission-guidelines?utm_source=medsci&utm_medium=display&utm_content=text_link&utm_campaign=BSCN_3_CZ01_CN_organic_MedSci_2020_publish, guideForAuthorHits=2054, submitWebsite=https://www.editorialmanager.com/jecc/default.aspx, submitWebsiteHits=21091, content=<p style="color: #333333;"><em>Journal of Experimental & Clinical Cancer Research</em> is an online peer-reviewed journal that publishes original research papers, reviews and commentaries in cancer research, from bench to bedside.<br /><br /><em>Journal of Experimental & Clinical</em><strong> </strong><em>Cancer Research</em> seeks manuscripts that include significant advances in basic cancer research and that offer a translational bridge from the laboratory to the clinic to open new avenues for the understanding, prevention, diagnosis and treatment of cancer.<br /><br />Specific areas of interest include, but are not limited to: mechanisms of progression of the malignant phenotype and metastatic disease; molecular alterations or biomarkers that predict response or resistance to treatment; translational research in targeted therapies; personalized medicine; novel applications of bioinformatics and biostatistics; tumor immunotherapy; large-scale molecular characterization of human tumors and innovative methods with potential applicability to clinical investigation.</p> <p style="color: #333333;">The following criteria provide an overview of the types of studies considered by the journal:</p> <ul style="color: #333333;"> <li>Findings that have not been previously published in the same tumor model.</li> <li>Studies performed in multiple cell lines.</li> <li>Conclusions that are not representative of incremental findings.</li> <li>Studies that include a clearly written title and abstract that communicate the study's impact of significance to non-experts.</li> </ul> <p style="color: #333333;">The online appearance of <em>Journal of Experimental & Clinical Cancer Research</em> allows the immediate publication of accepted articles and the presentation of large amounts of data and supplemental information to ensure that new research is disseminated as efficiently and quickly as possible to the scientific community.</p>, totalCites=23458, brief=J EXP CLIN CANC RES杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=肿瘤学" >肿瘤学</a></strong>”子行业的偏低级别杂志, articleType=绝大部分收录论著,也接收少量其它类型文章, medsciHeat=<span style="color: #ff0000;"><span style="color: #ff00ff;">洋红</span></span>, medsciComment=J EXP CLIN CANC RES是不错的SCI杂志,中国人文章也较容易被接收,竞争相对来说,也不算太残酷,强烈建议试试他们。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=56a17532'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=103), ImpactFactorTagDto(id=42190, tagName=肿瘤分子生物学, createdHits=8), ImpactFactorTagDto(id=5521, tagName=分子机制, createdHits=6), ImpactFactorTagDto(id=990, tagName=基因, createdHits=3), ImpactFactorTagDto(id=516, tagName=癌症, createdHits=2), ImpactFactorTagDto(id=803, tagName=Cancer, createdHits=2), ImpactFactorTagDto(id=437564, tagName=肿瘤增值, createdHits=2), ImpactFactorTagDto(id=4407, tagName=机制, createdHits=1), ImpactFactorTagDto(id=111501, tagName= 肿瘤 , createdHits=1), ImpactFactorTagDto(id=18272, tagName=疾病预防, createdHits=1), ImpactFactorTagDto(id=1559, tagName=肿瘤学, createdHits=1), ImpactFactorTagDto(id=123, tagName=Pathology, createdHits=1), ImpactFactorTagDto(id=1047, tagName=转移, createdHits=1), ImpactFactorTagDto(id=4090, tagName=儿童肿瘤, createdHits=1), ImpactFactorTagDto(id=5076, tagName=转录因子, createdHits=1), ImpactFactorTagDto(id=43811, tagName=肿瘤分子机制, createdHits=1), ImpactFactorTagDto(id=716, tagName=代谢, createdHits=1), ImpactFactorTagDto(id=34811, tagName=信号传导, createdHits=1), ImpactFactorTagDto(id=323, tagName=骨肿瘤, createdHits=1), ImpactFactorTagDto(id=1415, tagName=miRNA, createdHits=1), ImpactFactorTagDto(id=2964, tagName=分子生物学, createdHits=1), ImpactFactorTagDto(id=26235, tagName=口腔肿瘤, createdHits=1), ImpactFactorTagDto(id=15823, tagName=基因编辑, createdHits=1), ImpactFactorTagDto(id=706, tagName=血液学, createdHits=1), ImpactFactorTagDto(id=1586, tagName=自噬, createdHits=1), ImpactFactorTagDto(id=65765, tagName=nanomedincine, createdHits=1), ImpactFactorTagDto(id=65668, tagName=中草藥萃取物抗癌, createdHits=1), ImpactFactorTagDto(id=43478, tagName=Nanomedicine, createdHits=1), ImpactFactorTagDto(id=12049, tagName=垂体瘤, createdHits=1), ImpactFactorTagDto(id=1517, tagName=临床研究, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2014, citescore=0.0), GetImpactFactorCiteScoreListResponse(year=2017, citescore=5.57), GetImpactFactorCiteScoreListResponse(year=2018, citescore=5.34), GetImpactFactorCiteScoreListResponse(year=2019, citescore=7.9), GetImpactFactorCiteScoreListResponse(year=2020, citescore=0.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=50.772), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=46.832), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=34.906), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=24.341), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=26.053)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=35/321), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Cancer Research , rank=32/191)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=ONCOLOGY - SCIE, rank=Q1)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1756-9966[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH[ta], article_number=364, article_number_cn=209, earlyWarning=吉大一院预警, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
J EXP CLIN CANC RES/JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
ISSN
1756-9966
影响指数话题
预警等级
吉大一院预警
MedSci期刊指数
26.053 (MedSci实时期刊指数) | 50.0113 (5年期刊指数)
CiteScore值
0.0
h-index
81
h5-median
暂无数据
出版社/管理机构
杂志由 BioMed Central Ltd. 出版或管理
出版国家/地区
United Kingdom 英国
出版周期
Irregular
出版年份
1982
是否OA
被收录情况
暂无数据
JCR分区
ONCOLOGY - SCIE Q1
中科院分区
大类:医学 2区
小类: